GTC Biotherapeutics (fka GTCB)

[dodah_2]

The below is from the 2006 Annual Report. Is Genzyme the potential partner GTCB is currently negotiating with based on the below? Tia



"Our ability to negotiate with potential marketing partners may be limited.

If we choose to commercialize ATryn® with an additional marketing partner outside of Asia, Genzyme Corporation has an exclusive first right of negotiation for commercialization rights. This right is triggered on an indication-by-indication basis at such time as we apply for marketing approval with a regulatory
authority. This right does not apply if we have already entered into a collaboration or other agreement with a prospective research, development and marketing partner prior to such regulatory submission. For example, the right also does not apply to commercialization rights in Europe, Canada or the Middle East
for any indication because those rights are subject to our licensing and supply agreement entered into with LEO Pharma in October 2005. "